Skip to main content
Top

International Journal of Hematology

Issue 5/2002

Content (16 Articles)

The Notch Pathway: Modulation of Cell Fate Decisions in Hematopoiesis

K. Ohishi, B. Varnum-Finney, I. D. Bernstein

Case Report

Abnormal NK Cell Lymphocytosis Detected after Splenectomy: Association with Repeated Infections, Relapsing Neutropenia, and Persistent Polyclonal B-Cell Proliferation

Elisa Granjo, Margarida Lima, Manuela Fraga, Filipe Santos, Conceição Magalhães, Maria Luís Queirós, Ilidia Moreira, Sandra Rocha, Alice Santos Silva, Irene Rebelo, Alexandre Quintanilha, Maria Letícia Ribeiro, Jorge Candeias, Alberto Orfão

Case Report

Effect of Continuous Subcutaneous Administration of a Low Dose of G-CSF on Stem Cell Mobilization in Healthy Donors: A Feasibility Study

Junko Tanaka, Takaaki Miyake, Tadashi Shimizu, Toshio Wakayama, Michihiro Tsumori, Kunio Koshimura, Yoshio Murakami, Yuzuru Kato

Case Report

Long-Term Follow-up of Allogeneic Bone Marrow Transplantation after Reduced-Intensity Conditioning in Patients with Chronic Myelogenous Leukemia in the Chronic Phase

Shinichiro Okamoto, Reiko Watanabe, Satoshi Takahashi, Takehiko Mori, Tohru Izeki, Hitomi Nagayama, Akaru Ishida, Nobuyuki Takayama, Kenji Yokoyama, Arinobu Tojo, Shigetaka Asano, Yasuo Ikeda

Case Report

An Addition to Geographic Hematology: Chronic Myeloproliferative Diseases Are Infrequent in Mexican Mestizos

Guillermo J. Ruiz-Argüelles, Briceida López-Martínez, Eduardo Lobato-Mendizábal, Guillermo J. Ruiz-Delgado

Case Report

Fusion ofMLL andMSF in Adult De Novo Acute Myelomonocytic Leukemia (M4) with T(11;17)(Q23;Q25)

Koh Yamamoto, Fumi Shibata, Mitsuko Yamaguchi, Osamu Miura

Case Report

Pure Red Cell Aplasia Developing into Myeloproliferation with Myelodysplasia and Subsequent Leukemia after Cyclosporin A Therapy

Takahiro Yamauchi, Haruhisa Shirasaki, Atsushi Kuwata, Taro Yamashita, Shin Imamura, Hiroshi Tsutani, Takanori Ueda

Case Report

Flexible Low-Intensity Combination Chemotherapy for Elderly Patients with Acute Myeloid Leukemia

Arumugam Manoharan, Annette Trickett, Yiu Lam Kwan, Timothy Brighton

Case Report

Resveratrol, a Natural Product Derived from Grapes, Is a New Inducer of Differentiation in Human Myeloid Leukemias

Hiroya Asou, Kozo Koshizuka, Taiichi Kyo, Noboru Takata, Nanao Kamada, H. P. Koeffler

Case Report

Synergistic Growth Inhibition of YM529 with Biologic Response Modifiers (BRMs) in Myeloma Cells

Kenichiro Yata, Takemi Otsuki, Osamu Yamada, Hideho Wada, Yoshihito Yawata, Takashi Sugihara

Case Report

A Comparative Double-Blind Randomized Trial of Activated Protein C and Unfractionated Heparin in the Treatment of Disseminated Intravascular Coagulation

Nobuo Aoki, Tamotsu Matsuda, Hidehiko Saito, Kiyoshi Takatsuki, Kenji Okajima, Hoyu Takahashi, Junki Takamatsu, Hidesaku Asakura, Nobuya Ogawa

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine